statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	971
SG - Singapore	188
CN - Cina	139
IT - Italia	97
HK - Hong Kong	80
SE - Svezia	56
BR - Brasile	51
DE - Germania	50
BG - Bulgaria	31
VN - Vietnam	28
FR - Francia	25
GB - Regno Unito	23
CA - Canada	17
CI - Costa d'Avorio	17
IN - India	15
FI - Finlandia	12
RU - Federazione Russa	11
BE - Belgio	9
AT - Austria	8
BD - Bangladesh	8
JP - Giappone	7
NG - Nigeria	6
IQ - Iraq	5
PL - Polonia	5
UZ - Uzbekistan	5
AR - Argentina	4
SN - Senegal	4
ZA - Sudafrica	4
CR - Costa Rica	3
GR - Grecia	3
MX - Messico	3
NP - Nepal	3
OM - Oman	3
TR - Turchia	3
CZ - Repubblica Ceca	2
EG - Egitto	2
ES - Italia	2
ID - Indonesia	2
LT - Lituania	2
NL - Olanda	2
SA - Arabia Saudita	2
UA - Ucraina	2
UY - Uruguay	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AG - Antigua e Barbuda	1
AU - Australia	1
BH - Bahrain	1
BJ - Benin	1
BY - Bielorussia	1
CG - Congo	1
CO - Colombia	1
DK - Danimarca	1
GY - Guiana	1
HU - Ungheria	1
IE - Irlanda	1
JM - Giamaica	1
PE - Perù	1
PH - Filippine	1
PK - Pakistan	1
PY - Paraguay	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	1.932

Nome	#
Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight	182
IL-1 family cytokines and receptors in IgG4-related disease	169
Mediators of angiogenesis and fibrosis in IgG4-related disease.	167
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in mixed cryoglobulinemia.	163
Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis	162
18-FDG PET for large vessel vasculitis diagnosis and follow-up	159
New biomarkers in SLE: from bench to bedside	137
Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(®)) in immunodeficiency diseases: real-life data from a monocentric experience	133
One year in review 2017: pathogenesis of rheumatoid arthritis	131
Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review.	127
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study	124
null	101
Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers	86
The IgG4-related disease: performance of classification and diagnostic criteria in a single-centre cohort of patients	73
null	49
Totale	1.963

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	9	0	0	0	0	0	0	0	0	0	0	0	9
2021/2022	130	8	2	4	4	24	20	3	8	7	8	9	33
2022/2023	207	23	36	14	21	25	26	2	4	37	0	19	0
2023/2024	131	5	8	11	23	23	17	9	9	1	2	9	14
2024/2025	470	6	14	12	37	41	61	29	17	66	52	45	90
2025/2026	632	35	63	35	42	75	49	83	35	29	157	23	6
Totale													1.963

CINECA IRIS Institutional Research Information System